Skip to main content

Table 2 Patient and disease characteristics at entrance into BRASS cohort for subjects with ≥2 years of follow-up, in remission at one or more visit to any remission definition, and not in remission at entrance

From: Sustained rheumatoid arthritis remission is uncommon in clinical practice

N= 394 n(%)/Median (IQR)
Female 320 (81)
Age (years) 56 (45-63)
Positive anti-CCP or RF status 282 (72)
Smoking 24 (6)
Disease duration (years) 8 (2-19)
Any stiffness 286 (73)
Stiffness duration (minutes) 30-60 (10-90)
CRP (mg/L) 2.7 (1.1-7.9)
NSAIDs 244 (62)
Corticosteroids 103 (26)
MTX 196 (50)
Nonbiologic DMARDs
(not MTX)
137 (35)
Biologics 133 (34)
  1. CCP, cyclic citrullinated peptide; CRP, C-reactive protein; DMARD, disease-modifying antirheumatic drug; MTX, methotrexate; RF, rheumatoid factor.